Written By: Jon Suyko, PharmD, BCPS UCHealth Highlands Ranch
Description Venetoclax is as selective inhibitor of B cell lymphoma-2 (BCL-2). Inhibition of BCL-2 by venetoclax results in cytotoxic activity in tumor cells that overexpress BCL-2 by restoring apoptosis. Venetoclax is indicated in Acute myeloid leukemia (AML), chronic lymphoid leukemia (CLL) and small lymphocytic leukemia (SLL) in patients with or without chromosome 17p deletion. During the ramp-up phase, patients are titrated on venetoclax and assigned a risk category based on tumor burden and potential for developing Tumor Lysis Syndrome (TLS). These risk stratifications create special challenges for the dispensing of venetoclax. Some medium-risk and all high-risk patients may require hospital admission during titration; communication between the oncology pharmacist, nurse, lab technicians, hematologist, and the patient will ensure the recommended administration guidelines and lab monitoring are followed to ensure patient safety and best outcomes.
Continue reading Venetoclax Risk Stratification, Dosing, and Dispensing Procedure
New England Cancer Specialists (NECS) goal is our patients best outcomes. We strive to make life better for patients with cancer and blood disorders. Our core values are commitment, quality, respect, accountability, integrity, and innovation. Continue reading New England Cancer Specialists
The Mission of HOA is to provide the highest level of quality care in a healing environment for the mind, body and spirit of patients dealing with cancer and blood disorders. Our goal is to offer the highest level, state of the art technology and treatments, while meeting the emotional needs of our patients and their families. Continue reading Hematology Oncology Associates of Central New York
Joliet Oncology-Hematology Associates, Ltd. strives to continually improve the quality of life of our cancer patients; to provide patients with the highest quality of cancer care in an open supportive and compassionate environment; Continue reading Joliet Oncology-Hematology Associates, Ltd. And Presence Cancer Care